Recommendations and guidance for herpes zoster vaccination for adults in Taiwan.
Journal
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
ISSN
1995-9133
Date Issued
2024-06-21
Author(s)
Wang, Ching-Hsun
Su, Lian-Yi
Lin, I-Fan
Liu, Chia-Wei
Wu, Ping-Feng
Tsai, Wen-Chia
Chang, Chia-Ning
Hung, Miao-Chiu
Huang, Chien-Hsien
Chiu, Nan-Chang
Cheng, Ming-Fang
Wang, Ning-Chi
Wang, Hsiao-Wei
Wong, Swee Siang
Lin, Po-Chang
Tsai, Ming-Han
Yang, Shun-Cheng
Lin, Hsiao-Chuan
Lee, Susan Shin-Jung
Wang, Fu-Der
Abstract
Herpes zoster (HZ) is a painful, vesicular, cutaneous eruption from reactivation of varicella zoster virus (VZV), which can lead to potentially debilitating complications. The lifetime risk of HZ is estimated to be 20%-30% in the general population, with an increased risk in the elderly and immunocompromised populations. The most effective strategy to prevent HZ and its complications is by vaccination. Two types of HZ vaccines, zoster vaccine live and recombinant zoster vaccine, have been approved for use. This guidance offers recommendations and suggestions for HZ vaccination in adults, aiming to reduce the disease burden of HZ and its complications. It is intended as a guide to first-line healthcare providers, but does not supersede clinical judgement when assessing risk and providing recommendations to individuals. The Working Group on Adult Immunization Practice was appointed by the Infectious Diseases Society of Taiwan (IDST) and recommendations were drafted after a full literature review, using the Grading of Recommendation, Assessment, Development and Evaluation (GRADE) system. The recommendations were reviewed and revised by expert review panels during a series of consensus meetings and endorsed by the IDST, Taiwan Association of Family Medicine, the Taiwanese Dermatological Association, the Taiwan Oncology Society, the Taiwan Society of Blood and Marrow Transplantation, the Transplantation Society of Taiwan, the Taiwan AIDS Society, and the Taiwan College of Rheumatology. This guidance describes the epidemiology of HZ and provides recommendations for HZ vaccination in adults with varying levels of risk, differing history of previous VZV infection and past varicella or zoster vaccinations.
Type
review article